No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
COVID-19 / diagnosis
-
COVID-19 / epidemiology*
-
COVID-19 / genetics
-
COVID-19 Drug Treatment
-
Clinical Trials as Topic
-
Comorbidity
-
Genetic Predisposition to Disease
-
Humans
-
Mutation
-
Risk Factors
-
SARS-CoV-2 / metabolism
-
Serine Endopeptidases / metabolism
-
Serine Proteinase Inhibitors / pharmacology
-
Serine Proteinase Inhibitors / therapeutic use
-
Severity of Illness Index
-
Virus Internalization / drug effects
-
alpha 1-Antitrypsin / genetics*
-
alpha 1-Antitrypsin / metabolism
-
alpha 1-Antitrypsin / pharmacology
-
alpha 1-Antitrypsin / therapeutic use
-
alpha 1-Antitrypsin Deficiency / epidemiology*
-
alpha 1-Antitrypsin Deficiency / genetics
Substances
-
SERPINA1 protein, human
-
Serine Proteinase Inhibitors
-
alpha 1-Antitrypsin
-
Serine Endopeptidases
-
TMPRSS2 protein, human